Journal of Antimicrobial Chemotherapy (1981) 8, 305-316
© 1981 The British Society for Antimicrobial Chemotherapy
research-article |
Inhibition of clonal growth of Giardia lamblia and Entamoeba histolytica by metronidazole, quinacrine, and other antimicrobial agents
Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health Bethesda, Maryland 20205, U.S.A.
accepted 21 April 1981
A convenient new method has facilitated precise determination of the susceptibility of the parasitic protozoa Giardia lamblia and Entamoeba histolytica to a number of antimicrobial agents. Inhibition of clonal growth in semisolid media was used to quantitate killing of parasites as a function of drug concentration and exposure time. The minimum lethal concentration of metronidazole for G. lamblia (24 mg/l) was similar to that determined by microscopic observation and subculture of organisms in liquid medium. Both parasites were killed rapidly by metronidazole: 50% in 57 h at 2 mg/l or in 1 h at 10 mg/l. L-Cysteine decreased the susceptibility of both parasites to metronidazole and exerted a lesser protective effect on Giard. lamblia with quinacrine, emetine, and chloramphenicol. When metronidazole and quinacrine were tested in combination, no strong synergistic or antagonistic interactions were observed. The susceptibilities of these unrelated intestinal pathogens to a variety of drugs were similar. However, Giard, lamblia was more sensitive to quinacrine and less sensitive to several inhibitors of protein synthesis.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
R. Arguello-Garcia, M. Cruz-Soto, L. Romero-Montoya, and G. Ortega-Pierres Variability and variation in drug susceptibility among Giardia duodenalis isolates and clones exposed to 5-nitroimidazoles and benzimidazoles in vitro J. Antimicrob. Chemother., October 1, 2004; 54(4): 711 - 721. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. B. Gardner and D. R. Hill Treatment of Giardiasis Clin. Microbiol. Rev., January 1, 2001; 14(1): 114 - 128. [Abstract] [Full Text] [PDF] |
||||

